Progressive Resistance Training for Aging
(BRIO Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you stop taking certain medications, such as anti-coagulant or anti-platelet therapy, anabolic steroids, growth hormone, replacement androgen therapy, anti-androgen therapy, and weight loss medications. If you are on any of these, you would need to stop them to participate.
What data supports the effectiveness of the treatment Health Education, Progressive Resistance Training for aging?
Research shows that progressive resistance training can significantly improve muscle strength and size in older adults, which helps maintain independence and counteracts age-related muscle loss. Studies have demonstrated substantial increases in muscle strength and size after 8 to 12 weeks of training, making it an effective treatment for aging-related decline.12345
Is progressive resistance training safe for older adults?
How does progressive resistance training differ from other treatments for aging?
Progressive resistance training is unique because it specifically targets muscle strength and functional performance in older adults, helping to counteract age-related muscle loss and improve overall physical function. Unlike other treatments, it involves structured exercise routines that progressively increase in difficulty, which can lead to significant improvements in muscle size and strength.12347
What is the purpose of this trial?
To critically examine biological, clinical, and behavioral modulators of progressive resistance training-associated exercise response heterogeneity in physical function and whole-body metabolism in older adults.
Research Team
Nathan LeBrasseur, Ph.D, MS
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for sedentary adults aged 65 or older who are at risk of mobility disability but can still perform some physical activities. They should not be engaged in regular moderate exercise, have no recent participation in other trials, and must be willing to attend sessions at the clinical sites.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in progressive resistance training or health education sessions
Follow-up
Participants are monitored for changes in physical function and metabolic health
Treatment Details
Interventions
- Health Education
- Progressive Resistance Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Tufts University Jean Mayer USDA Human Nutrition Research Center on Aging
Collaborator